NCT03917251

Brief Summary

The study will examine role of transvenous pacing on coronary microcirculation.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2021

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 3, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 17, 2019

Completed
2.5 years until next milestone

Study Start

First participant enrolled

October 7, 2021

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 7, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 7, 2021

Completed
Last Updated

September 3, 2024

Status Verified

August 1, 2024

Enrollment Period

Same day

First QC Date

March 3, 2019

Last Update Submit

August 29, 2024

Conditions

Keywords

coronary microvascular dysfunction

Outcome Measures

Primary Outcomes (1)

  • Patients that exhibit coronary microvascular resistance and dysfunction as reflected by FFR

    Microvascular dysfunction with pacing

    Up to 12 months

Secondary Outcomes (1)

  • Patients that exhibit coronary microvascular resistance and dysfunction as reflected by CFR

    Up to 12 months

Study Arms (2)

Right ventricular Pacemaker

OTHER

Patients with right ventricular pacing and evidence of coronary ischemia who have evidence of coronary ischemia who are to undergo coronary angiogram.When an intermediate stenosis (40-80%) has been identified angiographically, this lesion will undergo further hemodynamic assessment, All data including resting flow, FFR, CFR, vital signs, arrhythmias and patient symptoms will be recorded twice: once when the pacemaker is programmed to pace, and once when the PPM is reprogrammed such that the pacemaker is no longer pacing.

Diagnostic Test: Coronary flow and pressure measurement in patients with ventricular pacing

Biventricular Pacemaker

OTHER

Patients with Biventricular pacing and evidence of coronary ischemia who have evidence of coronary ischemia who are to undergo coronary angiogram.When an intermediate stenosis (40-80%) has been identified angiographically, this lesion will undergo further hemodynamic assessment, All data including resting flow, FFR, CFR, vital signs, arrhythmias and patient symptoms will be recorded twice: once when the pacemaker is programmed to pace, and once when the PPM is reprogrammed such that the pacemaker is no longer pacing.

Diagnostic Test: Coronary flow and pressure measurement in patients with ventricular pacing

Interventions

Coronary flow and pressure measurement in patients with ventricular pacing

Biventricular PacemakerRight ventricular Pacemaker

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients 19 years of age or older with clinical evidence of coronary ischemia undergoing coronary angiogram, and who have a pacemaker.

You may not qualify if:

  • Acute ST segment myocardial infarction
  • Known sensitivity or contraindication to the agents planned for administration during coronary angiography
  • Pacemaker dependent patients
  • Pregnancy
  • Hypotension (a systolic blood pressure lower than 90mmHg) that would preclude the administration of adenosine
  • Severe renal dysfunction, defined as a estimated glomerular filtration (eGFR) less than 30ml/min, confirmed by recent testing
  • Study subject has any underlying disorder that, in the opinion of the investigator, precludes them from giving informed consent at the time of enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Microvascular Angina

Condition Hierarchy (Ancestors)

Angina PectorisMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Study Officials

  • Nashwa Abdulsalam, MD

    University of Nebraska

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 3, 2019

First Posted

April 17, 2019

Study Start

October 7, 2021

Primary Completion

October 7, 2021

Study Completion

October 7, 2021

Last Updated

September 3, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share